Quarterly report pursuant to Section 13 or 15(d)

Stockholder's Equity

v3.19.1
Stockholder's Equity
3 Months Ended
Mar. 31, 2019
Equity [Abstract]  
Stockholder's Equity

8.

Stockholder's Equity

Authorized, Issued, and Outstanding Common Stock

The Company’s authorized common stock has a par value of $0.001 per share and consists of 125,000,000 shares as of March 31, 2019, and December 31, 2018; 50,232,429 and 47,971,989 shares were issued and outstanding at March 31, 2019, and December 31, 2018, respectively. The following table summarizes common stock share activity for the three months ended March 31, 2019 and 2018 (dollars in thousands): 

 

 

 

Three Months Ended March 31, 2018

 

 

 

Shares of

Common Stock

 

 

Common

Stock

 

 

Additional

Paid-in

Capital

 

 

Accumulated

Deficit

 

 

Total

Stockholders'

Equity

 

Balance, January 1, 2018

 

 

28,971,651

 

 

$

29

 

 

$

226,631

 

 

$

(205,250

)

 

$

21,410

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(4,002

)

 

 

(4,002

)

Stock-based compensation expense

 

 

 

 

 

 

 

 

425

 

 

 

 

 

 

425

 

Common stock issued through employee stock purchase plan

 

 

13,591

 

 

 

 

 

 

20

 

 

 

 

 

 

20

 

Common stock issued, net of expenses

 

 

17,852,193

 

 

 

18

 

 

 

18,980

 

 

 

 

 

 

18,998

 

Common stock issued for vested restricted stock units

 

 

6,006

 

 

 

 

 

 

(7

)

 

 

 

 

 

(7

)

Balance, March 31, 2018

 

 

46,843,441

 

 

$

47

 

 

$

246,049

 

 

$

(209,252

)

 

$

36,844

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 2019

 

 

 

Shares of

Common Stock

 

 

Common

Stock

 

 

Additional

Paid-in

Capital

 

 

Accumulated

Deficit

 

 

Total

Stockholders'

Equity

 

Balance, January 1, 2019

 

 

47,971,989

 

 

$

48

 

 

$

248,895

 

 

$

(217,718

)

 

$

31,225

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(22,908

)

 

 

(22,908

)

Stock-based compensation expense

 

 

 

 

 

 

 

 

492

 

 

 

 

 

 

492

 

Common stock issued through employee stock purchase plan

 

 

19,259

 

 

 

 

 

 

20

 

 

 

 

 

 

20

 

Common stock issued, net of expenses

 

 

2,226,569

 

 

 

2

 

 

 

2,507

 

 

 

 

 

 

2,509

 

Common stock issued for vested restricted stock units

 

 

14,612

 

 

 

 

 

 

(8

)

 

 

 

 

 

(8

)

Balance, March 31, 2019

 

 

50,232,429

 

 

$

50

 

 

$

251,906

 

 

$

(240,626

)

 

$

11,330

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares Reserved for Future Issuance

The Company had reserved shares of common stock for future issuance as follows:

 

 

March 31, 2019

 

 

December 31, 2018

 

Outstanding stock options

 

5,310,498

 

 

 

4,052,913

 

Outstanding restricted stock units

 

990,301

 

 

 

111,891

 

Outstanding Series C-1 Preferred warrants

 

14,033

 

 

 

14,033

 

Warrants to purchase common stock associated with June 2016 Public Offering

 

4,218,750

 

 

 

4,218,750

 

Warrants to purchase common stock associated with March 2018 Public Offering - Series 1

 

 

 

 

13,198,075

 

Warrants to purchase common stock associated with March 2018 Public Offering - Series 2

 

7,988,175

 

 

 

7,988,175

 

Warrants to purchase common stock associated with Loan Agreement

 

122,435

 

 

 

122,435

 

For possible future issuance for the conversion of the 6% senior convertible notes

 

13,008,000

 

 

 

 

For possible future issuance under 2014 Equity Incentive Plan (Note 9)

 

372,312

 

 

 

612,018

 

For possible future issuance under Employee Stock Purchase Plan (Note 9)

 

91,819

 

 

 

81,667

 

For possible future issuance under 2015 Inducement Plan (Note 9)

 

5,000

 

 

 

5,000

 

Total common shares reserved for future issuance

 

32,121,323

 

 

 

30,404,957

 

Derivative Liability

In connection with the Company’s issuance of its Notes, the Company bifurcated the embedded conversion option, inclusive of the interest make-whole provision and make-whole fundamental change provision, and recorded the embedded conversion option as a long-term derivative liability in the Company’s balance sheet in accordance with ASC 815, Derivatives and Hedging.  The convertible debt and derivative liability associated with the Notes are presented in total on the accompanying unaudited balance sheet as the convertible debt and derivative liability.  In April 2019, Puissance converted $2.0 million of the Notes for 1,626,000 shares of common stock.

Warrants Associated with June 2016 and March 2018 Public Offerings

The outstanding warrants associated with the June 2016 and March 2018 public offerings contain a provision where the warrant holder has the option to receive cash, equal to the Black-Scholes fair value of the remaining unexercised portion of the warrant, as cash settlement in the event that there is a fundamental transaction (contractually defined to include various merger, acquisition or stock transfer activities). Due to this provision, ASC 480, Distinguishing Liabilities from Equity, requires that these warrants be classified as liabilities. The fair values of these warrants have been determined using the Black-Scholes valuation model, and the changes in the fair value are recorded in the accompanying statements of operations.  During the three months ended March 31, 2019 and 2018, the Company recorded a loss of $6.5 million and a gain of $3.6 million, respectively, due to the change in fair value of the warrant liabilities.  As of March 31, 2019, the fair value of the warrant liabilities was $7.5 million.

Warrant Associated with Solar Loan Agreement

Pursuant to the loan agreement, on the Closing Date the Company issued to Solar the warrant to purchase an aggregate of up to 122,435 shares of the Company’s common stock at an exercise price of $3.6754 per share. The warrant will expire five years from the date of the grant. The warrant was classified as equity and recorded at its relative fair value at issuance in the stockholders' equity section of the balance sheet.